Possibility of detecting intraductal papillary mucinous neoplasms using metabolite biomarkers for pancreatic cancer.

Conclusion: Metabolite biomarker candidates for PC are useful for detecting high-risk IPMN, which can progress to PC. PMID: 32940075 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32940075?dopt=Abstract

Source: Future Medicine: Biomarkers in Medicine - September 19, 2020 Category: Internal Medicine Tags: Biomark Med Source Type: research